Unlike the T cell receptor (TCR), CAR enables the recognition of antigens present on cancer cells, independently of MHC molecules, thus preventing cancer cells from evading immune system surveillance due to reduced MHC expression on their surface. This evidence concerns the gene HLA-C and cancer.